That was an unusually interesting Wikipedia article. It's wild to see a manufacturer so out in front to say "please don't make it a schedule III drug because we can't compete with the generic opiods." Remarkably like watching a movie producer argue in favor of a less restrictive rating. Except of course that the manufacturer can't opt for "this drug is unscheduled."

Mike